Related Experiment Videos
Huntington's disease: a molecular genetic and CT comparison
1Division of Clinical Neuroscience, St George's Hospital Medical School, University of London, UK.
Journal of Neurology, Neurosurgery, and Psychiatry
|February 1, 1996
Summary
Cranial CT scans can detect caudate head atrophy in Huntington's disease (HD) patients. However, CT sensitivity is insufficient for routine diagnosis, especially when genetic testing is available.
Area of Science:
- Neuroscience
- Radiology
- Genetics
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Diagnosis historically relied on clinical findings and neuroimaging (CT/MRI).
- Molecular markers for HD are now available.
Purpose of the Study:
- To validate CT imaging findings of caudate nucleus atrophy against the molecular marker for Huntington's disease.
- To assess the diagnostic sensitivity of CT scans in identifying Huntington's disease.
Main Methods:
- Retrospective analysis of cranial CT scans.
- Comparison of caudate head size between 16 HD patients and 16 age/sex-matched controls.
- Utilized molecular test as the gold standard for diagnosis.
Main Results:
- A highly significant difference in caudate head size was observed between HD patients and controls (P < 0.00001).
- The sensitivity of CT for diagnosing Huntington's disease in this study was 87.5%.
- Significant caudate atrophy is indicative of HD.
Conclusions:
- While CT shows significant caudate head atrophy in Huntington's disease, its sensitivity is insufficient for routine diagnostic use.
- CT may be useful in excluding other diagnoses when genetic tests are negative or unavailable.
- Molecular testing remains the preferred diagnostic method for Huntington's disease.